On the Horizon - upcoming first generic launches*

4Q2019 OSMOPREP Sodium Phosphate electrolytes Bowel prep for colonoscopy $8M
4Q2019 ACZONE 7.5% Dapsone Acne   $263M
2020 ATRIPLA Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate HIV/AIDS $1,273M
2020 TRUVADA Emtricitabine; Tenofovir Disoproxil Fumarate HIV/AIDS $3,151M
2020 KUVAN Sapropterin Dihydrochloride Phenylketonuria $25M
2020 AFINITOR  Everolimus Kidney cancer $394M
2020 SILENOR Doxepin Hydrochloride Insomnia $47M
2020 CHANTIX Varenicline Tartrate Smoking cessation $702M
2020 ABSORICA Isotretinoin Acne   $308M
2020 CIPRODEX Ciprofloxacin; Dexamethasone Ear Infections $466M
2020 DALIRESP Roflumilast COPD $214M
2020 VELCADE Bortezomib Lymphomas $610M

* Source: IPD Analytics, www.ipdanalytics.com, Accessed August 27, 2019

Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names

Health benefit plans vary, but in general to be eligible for coverage a drug must be approved by the Food and Drug Administration (FDA), prescribed by a health care professional, purchased from a licensed pharmacy and medically necessary. Some plans require use an in-network pharmacy for prescriptions to be covered. Coverage is subject to any plan deductible, copayment and/or coinsurance requirements. Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and complete details of prescription drug coverage, contact a Cigna representative.

All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Cigna Behavioral Health, Inc., Cigna Health Management, Inc., Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.

© 2021 Cigna. All rights reserved